View in EDS HTML Full Text PDF Full Text

Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung.

Saved in:
Bibliographic Details
Title: Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung.
Authors: Wang, Daren1 (AUTHOR), Chang, Albert2,3 (AUTHOR), Shea, Fortune1,3 (AUTHOR), He, Yifei2,4 (AUTHOR), Spinney, Richard4,5 (AUTHOR), Whitsett, Jonathan D.1,6 (AUTHOR), Lahann, Joerg2,3,5,6,7 (AUTHOR), Mallery, Susan R.1,7 (AUTHOR) mallery.1@osu.edu
Source: Pharmaceutics. Nov2025, Vol. 17 Issue 11, p1471. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994923
DOI:10.3390/pharmaceutics17111471